Company profile
Kainova Therapeutics company profile
Kainova Therapeutics is a biopharmaceutical company located in Strasbourg, France, dedicated to the discovery and early development of small molecules targeting G-coupled Protein Receptors (GPCRs), one of the best classes of drug targets. Domain Therapeutics is using its innovative and proprietary technology platform DTect-All™ to identify orthosteric and allosteric ligands of GPCRs, including the so called Silent Allosteric Modulators (SAMs) that represent a unique source of compounds that cannot be discovered by standard technologies. DTect-All™ is able to address difficult GPCRs such as orphan and peptidic GPCRs.
Business identity
- Contact email
- [email protected]
- Phone number
- +33 3 90 40 61 50
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00101-00250 employees
- Revenue range
- $1K+
- Founded
- 2001-01-01
Headquarters
- Headquarters
- Illkirch-Graffenstaden, Grand Est, France
- Country code
- FR
- Continent
- Europe